Butibel Interactions
There are 663 drugs known to interact with Butibel (belladonna / butabarbital), along with 30 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 41 are major, 588 are moderate, and 34 are minor.
- View all 663 medications that may interact with Butibel
- View Butibel alcohol/food interactions (2)
- View Butibel disease interactions (30)
Most frequently checked interactions
View interaction reports for Butibel (belladonna / butabarbital) and the medicines listed below.
- Abilify (aripiprazole)
- acetazolamide
- Actos (pioglitazone)
- acyclovir
- Adderall XR (amphetamine / dextroamphetamine)
- Aggrenox (aspirin / dipyridamole)
- allopurinol
- alprazolam
- amitriptyline
- amlodipine
- anagrelide
- Asacol HD (mesalamine)
- atenolol
- atenolol / chlorthalidone
- atorvastatin
- Avalide (hydrochlorothiazide / irbesartan)
- baclofen
- Bear-E-Yum GI (barium sulfate)
- Benicar (olmesartan)
- butalbital
- Bystolic (nebivolol)
- Carafate (sucralfate)
- carbidopa
- carvedilol
- Celexa (citalopram)
- Cephadyn (acetaminophen / butalbital)
- cetirizine
- ChlorTan (chlorpheniramine)
- Cialis (tadalafil)
- citalopram
Butibel alcohol/food interactions
There are 2 alcohol/food interactions with Butibel (belladonna / butabarbital).
Butibel disease interactions
There are 30 disease interactions with Butibel (belladonna / butabarbital) which include:
- autonomic neuropathy
- GI obstruction
- glaucoma
- obstructive uropathy
- reactive airway diseases
- myasthenia gravis
- infectious diarrhea
- acute alcohol intoxication
- drug dependence
- liver disease
- porphyria
- rash
- respiratory depression
- cardiac disease
- tachycardia
- coronary artery disease
- gastric ulcer
- gastroesophageal reflux
- ulcerative colitis
- liver disease
- renal failure
- adrenal insufficiency
- depression
- hematologic toxicity
- osteomalacia
- paradoxical reactions
- hypertension
- hyperthyroidism
- diarrhea
- fever
Report options
QR code containing a link to this page
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.